In HNSCC, EGF family ligand expression, including EREG, associates with better responses to the EGFR inhibitor cetuximab, reflecting the increased dependence on EGFR signaling in these cancers (53). This evidence concerns the gene EREG and head and neck squamous cell carcinoma.